Inhibition of both c-Met and EGFR signaling shows synergistic antitumor activity in non-small cell lung cancer model

被引：1
|
作者：
Tammam, Jennifer G.
Davis, Lenora
Ware, Chris
Reilly, John F.
Deshmukh, Sujal V.
Dinsmore, Christopher
Marshall, Gary
Harrington, Elizabeth A.
Pan, Bo-Sheng
Lutterbach, Bart A.
Majumder, Pradip K.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C209
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer
    Fong, Jason T.
    Jacobs, Ryan J.
    Moravec, David N.
    Uppada, Srijayaprakash B.
    Botting, Gregory M.
    Nlend, Marie
    Puri, Neelu
    PLOS ONE, 2013, 8 (11):
  • [12] Evaluation of c-Met FISH on Non-Small Cell Lung Cancer Samples with Known EGFR Mutational Status
    Bloom, K. J.
    Ha, T.
    Uyeda, L.
    Choppa, P.
    MODERN PATHOLOGY, 2012, 25 : 473A - 473A
  • [13] Evaluation of c-Met FISH on Non-Small Cell Lung Cancer Samples with Known EGFR Mutational Status
    Bloom, K. J.
    Uyeda, L.
    Choppa, P.
    LABORATORY INVESTIGATION, 2012, 92 : 473A - 473A
  • [14] INTEGRIN BETA1 MEDIATES EGFR TKI RESISTANCE THROUGH C-MET SIGNALING PATHWAY IN NON-SMALL CELL LUNG CANCER
    Ju, L.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [15] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
  • [16] The role of HGF/C-met signalling pathway on the non-small cell lung cancer
    Gumustekin, M.
    Sis, B.
    Bulut, G.
    Kargi, A.
    Oztop, I.
    Olgun, N.
    Atabey, N.
    FEBS JOURNAL, 2006, 273 : 89 - 89
  • [17] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [18] PROTEASOME INHIBITORS REDUCE C-MET IN NON-SMALL CELL LUNG CANCER CELLS
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Zhao, Yutong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1117 - 1118
  • [19] HGF/c-Met Overexpressions, but not Met Mutation, Correlates with Progression of Non-small Cell Lung Cancer
    Gumustekin, Mukaddes
    Kargi, Aydanur
    Bulut, Gulay
    Gozukizil, Aysim
    Ulukus, Cagnur
    Oztop, Ilhan
    Atabey, Nese
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 209 - 218
  • [20] Profiling c-Met and EGFR kinase inhibitor resistance pathways in non-small lung cancer cells
    Bomgarden, Ryan D.
    Jacobs, Ryan
    Fong, Jason
    Moravec, David
    Botting, Gregory M.
    Blank, Michael
    Viner, Rosa I.
    Rogers, John C.
    Puri, Neelu
    CANCER RESEARCH, 2014, 74 (19)
12345